TENX Crashes 90% as Short Interest Doubles and Options Turn Defensive
Tenax Therapeutics heads into its August 13 earnings report as one of the most dramatic single-week collapses in the biotech space, with a 90% price drop forcing a complete re-read of the positioning signals that…